Stock AMDA ALMEDA VENTURES LIMITED PARTNERSHIP
Add to a list
To use this feature you must be a member
Log inSign up

Financials Almeda Ventures Limited Partnership

Equities

AMDA

IL0011689622

Advanced Medical Equipment & Technology

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 15:24:43 13/06/2024 BST 		5-day change 1st Jan Change
189.5 ILa +3.84% Intraday chart for Almeda Ventures Limited Partnership +2.43% -7.56%
03-18 Almeda Ventures Limited Partnership Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 BioProtect Ltd. announced that it has received $28 million in funding from MVM Partners LLP, Triventures, KB Investment Co., Ltd., Peregrine Ventures, Almeda Ventures Limited Partnership, Vincos Limited CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 15.22 18.01 4.65 7.021
Enterprise Value (EV) 1 2.66 8.713 -1.135 4.183
P/E ratio - 487 x -7.29 x -4.37 x
Yield - - - -
Capitalization / Revenue - 11,280,119 x 5,126,484 x -24,043,572 x
EV / Revenue - 5,456,074 x -1,251,686 x -14,324,394 x
EV / EBITDA - 248,952,880 x 1,782,228 x -2,695,053 x
EV / FCF - 45,176,154 x 2,998,427 x -4,645,534 x
FCF Yield - 0% 0% -0%
Price to Book - 0.66 x 0.17 x 0.27 x
Nbr of stocks (in thousands) 6,909 12,322 12,322 12,370
Reference price 2 2.203 1.462 0.3774 0.5676
Announcement Date 17/02/21 20/03/22 28/03/23 18/03/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales - 1.597 0.907 -0.292
EBITDA - 0.035 -0.637 -1.552
EBIT 1 -0.6257 0.034 -0.639 -1.63
Operating Margin - 2.13% -70.45% 558.22%
Earnings before Tax (EBT) 1 -0.4714 0.052 -0.641 -1.582
Net income 1 -0.4714 0.052 -0.64 -1.58
Net margin - 3.26% -70.56% 541.1%
EPS - 0.003000 -0.0517 -0.1300
Free Cash Flow - 0.1929 -0.3786 -0.9004
FCF margin - 12.08% -41.74% 308.35%
FCF Conversion (EBITDA) - 551.07% - -
FCF Conversion (Net income) - 370.91% - -
Dividend per Share - - - -
Announcement Date 17/02/21 20/03/22 28/03/23 18/03/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 - - - -
Net Cash position 1 12.6 9.3 5.79 2.84
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - 0.19 -0.38 -0.9
ROE (net income / shareholders' equity) - 0.22% -2.36% -6.06%
ROA (Net income/ Total Assets) - 0.09% -1.45% -3.85%
Assets 1 - 57.59 44.22 41.09
Book Value Per Share - 2.220 2.170 2.130
Cash Flow per Share - 0.7700 0.4800 0.1000
Capex - 0 - -
Capex / Sales - 0.13% - -
Announcement Date 17/02/21 20/03/22 28/03/23 18/03/24
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ALMEDA VENTURES LIMITED PARTNERSHIP Stock Almeda Ventures Limited Partnership
-7.56% 6.31M
DANAHER CORPORATION Stock Danaher Corporation
+10.16% 189B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+26.21% 150B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+32.78% 113B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.98% 65.05B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+14.48% 52.83B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+2.92% 49.39B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-6.60% 38.1B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
-1.07% 35.14B
RESMED, INC. Stock ResMed, Inc.
+23.08% 31.2B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. AMDA Stock
  4. Financials Almeda Ventures Limited Partnership
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW